Alok Mehrotra

Bicara Therapeutics, Inc. is a company that develops first-in-class bifunctional antibodies for the treatment of solid tumors. The company is based in Cambridge, MA. The company's lead product candidate, bca101, is a first-in-class egfr/tgf-?-trap bifunctional antibody in clinical development for multiple tumor types. The company's bifunctional antibodies are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, offering the potential for synergistic therapeutic impact at the site of the tumor. Bicara has a deep pipeline of promising bifunctional antibodies and other biologics for treating solid tumors. The CEO of the company is Claire Mazumdar.

Immuneel Therapeutics Pvt Ltd. operates as a cancer treatment center. The company was founded by Kiran Mazumdar-Shaw, Kush M. Parmar and Siddhartha Mukherjee is headquartered in Bengaluru, India.

Part of GSK Plc, GlaxoSmithKline Intellectual Property Management Ltd. is a British biopharma company focused on unlocking the science of the immune system to understand how the body's defence system reacts to disease. The company is based in Brentford, UK. GSK offers a portfolio of brands and educational resources for patients and healthcare professionals. GSK has recently acquired TESARO, an oncology-focused company, and has launched a tracing programme in partnership with ProSearch to reunite lost shareholders with unclaimed entitlements.

Founded in 2014, GlaxoSmithKline Consumer Healthcare (UK) Trading Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. Part of GSK Plc, the company is based in Middlesex, UK.

Part of GSK Plc, GlaxoSmithKline Consumer Healthcare (Overseas) Ltd. is a British company that offers Voltarol patches and plasters for effective pain relief. The company is based in Brentford, UK. The text from the 'description' mentions that Voltarol offers different kinds of patches and plasters for pain relief and provides information on common causes of foot and ankle pain. The company was founded in 2014.

Part of GSK Plc, GlaxoSmithKline Consumer Healthcare (UK) IP Ltd. engages in licensing intellectual property rights related to consumer healthcare products. The company is based in Middlesex, UK.

Part of GSK Plc, GlaxoSmithKline Export Ltd. is a British biopharma company founded in 1989. The company is based in Middlesex, UK. GlaxoSmithKline Export aims to unite science, technology, and talent to get ahead of disease together. The company's pipeline is focused on unlocking the science of the immune system and advanced technologies to develop innovative vaccines and medicines.

Part of GSK Plc, GlaxoSmithKline Holdings (One) Ltd. functions as an investment holding British company. The company is based in Brentford, UK.

Part of GSK Plc, GlaxoSmithKline Holdings (Ireland) Ltd. provides financial management services. The company is based in Brentford, UK. Founded in 2014.

Part of GSK Plc, GlaxoSmithKline IHC Ltd. provides banking services. The company is based in Middlesex, UK.

Part of GSK Plc, GlaxoSmithKline Intellectual Property (No. The company is based in Brentford, UK. The British company combines human genetics, genomics, and advanced technologies to develop more effective vaccines and medicines. This privacy notice applies to any individual who is a current or former registered shareholder of GSK Plc. The company's purpose is to unite science, technology, and talent to get ahead of disease together. 2) Ltd. is a biopharma company founded in 2012.

Part of GSK Plc, Glaxosmithkline Investment Holdings Ltd. functions as an investment holding British company. The company is based in Brentford, UK and was founded in 2009.

Part of GSK Plc, GlaxoSmithKline Intellectual Property Development Ltd. is a British biopharma company founded in 2012. The company is based in Middlesex, UK. GlaxoSmithKline Intellectual Property Development unites science, technology, and talent to get ahead of disease together. The company recently completed a transaction to combine its consumer healthcare businesses into a new Joint Venture.

Part of GSK Plc, GlaxoSmithKline Intellectual Property Holdings Ltd. functions as an investment holding British company. The company is based in Brentford, UK.

Part of GSK Plc, Glaxosmithkline Investment Services Ltd. provides business support services. The company is based in Middlesex, UK and was founded in 2009.

Part of GSK Plc, GlaxoSmithKline Investments (Ireland) Ltd. functions as an investment holding Irish company. The company is based in Dublin, Ireland.

Horlicks Ltd. manufactures and distributes infant food products. The products it offers are Horlicks traditional, light and light chocolate. The company was founded on December 11, 1925 and is headquartered in Brentford, the United Kingdom.

Part of GSK Plc, Smithkline Beecham (Export) Ltd. is a holding British company that provides loan services through its subsidiaries. The company is based in Brentford, UK.

Founded in 1996, Smithkline Beecham (H) Ltd. is a British company that functions as an investment holding company. Part of GSK Plc, the company is based in Brentford, UK.

Founded in 1935, Smithkline Beecham (Investments) Ltd. is a subsidiary of GSK Plc and provides investment services. The company is based in Middlesex, UK.

Part of GSK Plc, Smithkline Beecham Marketing & Technical Services Ltd. provides marketing services for healthcare products. The company is based in Brentford, UK.

Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Holdings Ltd. functions as an investment holding British company. The company is based in Brentford, UK.

Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Ireland IP Ltd. is a company headquartered in Carrigaline, Ireland, that provides business services.

Founded in 2014, GlaxoSmithKline Consumer Healthcare Finance Ltd. is a British company that provides investment services. Part of GSK Plc, the company is based in Brentford, UK.

GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.

Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT.

Rallybio Holdings LLC engages in the provision of healthcare services. The company is headquartered in New Haven, CT.

Grace Science Foundation is a biotechnology company that was founded in 2017 by Matt Wilsey and Dr. Carolyn Bertozzi. The private company is based in San Francisco, CA. The company focuses on developing novel therapies based on the function of NGLY1, a key enzyme involved in proteostasis. Grace Science Foundation's deep knowledge of the NGLY1 pathway enables them to identify new ways of treating NGLY1 deficiency as well as more common diseases.

Part of GSK Plc, Smithkline Beecham Nominees Ltd. acts as a nominee/trust/depository. The company is based in Brentford, UK.

Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir.

Precede Biosciences is a company that aims to improve success rates in drug development and clinical practice by breaking down the barriers to precision medicine. The company is based in Boston, MA. The company seeks to redefine what can be learned from a simple blood draw to better target medicines to the right patients. Precede Biosciences is revolutionizing precision medicine by revealing unprecedented insights into disease-defining biology from a simple blood test. The CEO of the company is Rehan Verjee.

Part of GSK Plc, Dealcyber Ltd. is a British biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. Founded in 1998, the company is based in Middlesex, UK. We’re looking for the world’s best talent to help us discover and develop new products. Explore innovations from inside and outside our labs. Go #BehindTheScience to see for yourself.

Founded in 1935, Glaxo Group Ltd. is a subsidiary of GSK Plc. The company is based in Middlesex, UK. At GSK, we unite science, technology and talent to get ahead of disease together.